$YTENQ
YIELD10 BIOSCIENCE, INC.

2015 Q2 Form 10-Q Financial Statement

#000112170215000019 Filed on May 14, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2015 Q1 2014 Q1
Revenue $744.0K $645.0K $613.0K
YoY Change 6.44% 5.22% -51.0%
Cost Of Revenue $90.00K $84.00K $166.0K
YoY Change -78.57% -49.4% -70.2%
Gross Profit $654.0K $561.0K $447.0K
YoY Change 134.41% 25.5% -35.59%
Gross Profit Margin 87.9% 86.98% 72.92%
Selling, General & Admin $2.464M $2.466M $3.132M
YoY Change -7.54% -21.26% -5.43%
% of Gross Profit 376.76% 439.57% 700.67%
Research & Development -$560.0K $3.930M $4.810M
YoY Change -112.79% -18.3% -1.03%
% of Gross Profit -85.63% 700.53% 1076.06%
Depreciation & Amortization $40.00K $55.00K $191.0K
YoY Change -71.43% -71.2% -35.25%
% of Gross Profit 6.12% 9.8% 42.73%
Operating Expenses $2.464M $2.466M $3.132M
YoY Change -7.54% -21.26% -5.43%
Operating Profit -$6.129M -$5.830M -$7.491M
YoY Change -9.36% -22.17% 11.29%
Interest Expense $1.000K $1.000K $5.000K
YoY Change -133.33% -80.0% -50.0%
% of Operating Profit
Other Income/Expense, Net $56.00K -$13.00K $6.000K
YoY Change 1300.0% -316.67% -72.73%
Pretax Income -$380.0K -$5.840M -$7.490M
YoY Change -94.38% -22.03% 10.8%
Income Tax
% Of Pretax Income
Net Earnings -$6.073M -$5.843M -$8.154M
YoY Change -16.06% -28.34% 20.62%
Net Earnings / Revenue -816.26% -905.89% -1330.18%
Basic Earnings Per Share -$0.23
Diluted Earnings Per Share -$86.71M -$97.33M -$0.23
COMMON SHARES
Basic Shares Outstanding 135.5M shares 135.4M shares 34.81M shares
Diluted Shares Outstanding 34.81M shares

Balance Sheet

Concept 2015 Q2 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $22.70M $13.30M $10.40M
YoY Change 312.73% 27.88% -72.41%
Cash & Equivalents $22.71M $13.26M $3.606M
Short-Term Investments $6.800M
Other Short-Term Assets $1.600M $800.0K $1.100M
YoY Change 128.57% -27.27% 57.14%
Inventory $600.0K $555.0K $3.756M
Prepaid Expenses
Receivables $600.0K $139.0K $446.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $25.50M $25.47M $16.01M
YoY Change 152.48% 59.04% -63.4%
LONG-TERM ASSETS
Property, Plant & Equipment $743.0K $743.0K $456.0K
YoY Change 23.83% 62.94% -59.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $700.0K $95.00K $95.00K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $1.400M $1.457M $1.414M
YoY Change 7.69% 3.04% -21.84%
TOTAL ASSETS
Total Short-Term Assets $25.50M $25.47M $16.01M
Total Long-Term Assets $1.400M $1.457M $1.414M
Total Assets $26.90M $26.93M $17.43M
YoY Change 135.96% 54.49% -61.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $400.0K $384.0K $505.0K
YoY Change 0.0% -23.96% 448.91%
Accrued Expenses $3.184M $3.184M $2.616M
YoY Change -0.5% 21.71% -2.35%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.800M $3.814M $3.905M
YoY Change -13.64% -2.33% -0.08%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $200.0K $150.0K $148.0K
YoY Change 0.0% 1.35% 10.45%
Total Long-Term Liabilities $200.0K $150.0K $148.0K
YoY Change 0.0% 1.35% 10.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.800M $3.814M $3.905M
Total Long-Term Liabilities $200.0K $150.0K $148.0K
Total Liabilities $4.000M $3.964M $4.053M
YoY Change -11.11% -2.2% -0.07%
SHAREHOLDERS EQUITY
Retained Earnings -$314.0M -$280.7M
YoY Change 11.86% 12.82%
Common Stock $337.0M $349.0K
YoY Change 96467.05% -99.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.00M $22.96M $13.38M
YoY Change
Total Liabilities & Shareholders Equity $26.90M $26.93M $17.43M
YoY Change 135.96% 54.49% -61.75%

Cashflow Statement

Concept 2015 Q2 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income -$6.073M -$5.843M -$8.154M
YoY Change -16.06% -28.34% 20.62%
Depreciation, Depletion And Amortization $40.00K $55.00K $191.0K
YoY Change -71.43% -71.2% -35.25%
Cash From Operating Activities -$5.470M -$6.661M -$8.965M
YoY Change 12.09% -25.7% 5.47%
INVESTING ACTIVITIES
Capital Expenditures -$80.00K $127.0K $100.0K
YoY Change 27.0% 56.25%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $4.700M
YoY Change -100.0% -100.0% -67.61%
Cash From Investing Activities -$80.00K -$130.0K $4.600M
YoY Change -101.17% -102.83% -68.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 15.00M 0.000 300.0K
YoY Change -100.0% 2900.0%
NET CHANGE
Cash From Operating Activities -5.470M -$6.661M -$8.965M
Cash From Investing Activities -80.00K -130.0K 4.600M
Cash From Financing Activities 15.00M 0.000 300.0K
Net Change In Cash 9.450M -$6.661M -$8.965M
YoY Change 389.64% -25.7% -250.67%
FREE CASH FLOW
Cash From Operating Activities -$5.470M -$6.661M -$8.965M
Capital Expenditures -$80.00K $127.0K $100.0K
Free Cash Flow -$5.390M -$6.788M -$9.065M
YoY Change 10.45% -25.12% 5.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 dei Amendment Flag
AmendmentFlag
false
CY2015Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2015Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015Q1 dei Document Period End Date
DocumentPeriodEndDate
2015-03-31
CY2015Q1 dei Document Type
DocumentType
10-Q
CY2015Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001121702
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
135540088 shares
CY2015Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015Q1 dei Entity Registrant Name
EntityRegistrantName
METABOLIX, INC.
CY2014Q4 mblx Accrued Commercial Manufacturing Current
AccruedCommercialManufacturingCurrent
77000 USD
CY2015Q1 mblx Accrued Commercial Manufacturing Current
AccruedCommercialManufacturingCurrent
97000 USD
CY2014Q1 mblx Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
169000 USD
CY2015Q1 mblx Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
137000 USD
CY2014Q1 mblx Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
4812000 USD
CY2015Q1 mblx Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
3925000 USD
CY2014Q1 mblx Increase Decrease In Deferred Rent And Long Term Liabilities
IncreaseDecreaseInDeferredRentAndLongTermLiabilities
-38000 USD
CY2015Q1 mblx Increase Decrease In Deferred Rent And Long Term Liabilities
IncreaseDecreaseInDeferredRentAndLongTermLiabilities
0 USD
CY2014Q1 mblx License And Royalty Revenue
LicenseAndRoyaltyRevenue
63000 USD
CY2015Q1 mblx License And Royalty Revenue
LicenseAndRoyaltyRevenue
121000 USD
CY2014Q3 mblx Number Of Units Purchased
NumberOfUnitsPurchased
50000000 item
CY2015Q1 mblx Period Over Which Capital Resources Are Not Sufficient To Fund Planned Operations
PeriodOverWhichCapitalResourcesAreNotSufficientToFundPlannedOperations
P12M
CY2014Q3 mblx Unit Price
UnitPrice
0.50
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
333000 USD
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
288000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
45000 USD
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
174000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3709000 USD
CY2015Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2653000 USD
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
564000 USD
CY2015Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
516000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-64000 USD
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-68000 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
319580000 USD
CY2015Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
319960000 USD
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8074259 shares
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6617891 shares
CY2014Q4 us-gaap Assets
Assets
23135000 USD
CY2015Q1 us-gaap Assets
Assets
16670000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
21965000 USD
CY2015Q1 us-gaap Assets Current
AssetsCurrent
15428000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7698000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3606000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20046000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13257000 USD
CY2014Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-534000 USD
CY2015Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
135353764 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34581449 shares
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34581449 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
135353764 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
1352000 USD
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
1353000 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8181000 USD
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5847000 USD
CY2014Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
166000 USD
CY2015Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
84000 USD
CY2014Q1 us-gaap Costs And Expenses
CostsAndExpenses
8110000 USD
CY2015Q1 us-gaap Costs And Expenses
CostsAndExpenses
6475000 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
147000 USD
CY2015Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
249000 USD
CY2012 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
38885000 USD
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
191000 USD
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
55000 USD
CY2014Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-663000 USD
CY2015Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
0 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2371000 USD
CY2014Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare
-0.02
CY2015Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare
0.00
CY2014Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
112000 USD
CY2015Q1 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
94000 USD
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2014Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-25000 USD
CY2015Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-1000 USD
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2621000 USD
CY2015Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1700000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-7491000 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-5843000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.21
CY2015Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.04
CY2014Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-663000 USD
CY2015Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-74000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-45000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-551000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
129000 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1128000 USD
CY2014Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
101000 USD
CY2015Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
102000 USD
CY2014Q1 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-51000 USD
CY2015Q1 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-18000 USD
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-189000 USD
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-15000 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
434000 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
18000 USD
CY2014Q1 us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
60000 USD
CY2015Q1 us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
138000 USD
CY2014Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
5000 USD
CY2015Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1000 USD
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
584000 USD
CY2015Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
570000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
586000 USD
CY2015Q1 us-gaap Inventory Net
InventoryNet
571000 USD
CY2014Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2000 USD
CY2015Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1000 USD
CY2015Q1 us-gaap Investments And Cash
InvestmentsAndCash
13257000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
4339000 USD
CY2015Q1 us-gaap Liabilities
Liabilities
3340000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23135000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-127000 USD
CY2015Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
-319 USD
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16670000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4189000 USD
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3190000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-4092000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-6789000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
300000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
0 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
4598000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8965000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6661000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-8431000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6661000 USD
CY2014Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8154000 USD
CY2015Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5843000 USD
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6000 USD
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13000 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7497000 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5830000 USD
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
447000 USD
CY2015Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
340000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
95000 USD
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
95000 USD
CY2014Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-26000 USD
CY2015Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4000 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-27000 USD
CY2015Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4000 USD
CY2014Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000 USD
CY2015Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2014Q4 us-gaap Other Inventory In Transit
OtherInventoryInTransit
9000 USD
CY2015Q1 us-gaap Other Inventory In Transit
OtherInventoryInTransit
20000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
150000 USD
CY2015Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
150000 USD
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000 USD
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-14000 USD
CY2014Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
86000 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
100000 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
127000 USD
CY2014Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
1508000 USD
CY2015Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
50000 shares
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
50000 shares
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
756000 USD
CY2015Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
774000 USD
CY2014Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
24914000 USD
CY2014Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
25000 USD
CY2014Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
6206000 USD
CY2015Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0 USD
CY2014Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
300000 USD
CY2015Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
456000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
456000 USD
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
528000 USD
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
619000 USD
CY2015Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
619000 USD
CY2015Q1 us-gaap Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
35 USD
CY2014Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
624 USD
CY2015Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
340 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-302072000 USD
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-307915000 USD
CY2014Q1 us-gaap Revenue From Grants
RevenueFromGrants
448000 USD
CY2015Q1 us-gaap Revenue From Grants
RevenueFromGrants
452000 USD
CY2014Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
102000 USD
CY2015Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
72000 USD
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
613000 USD
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
645000 USD
CY2014Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3132000 USD
CY2015Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2466000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
785000 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
313000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
18796000 USD
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
13330000 USD
CY2014Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
420000 USD
CY2015Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
558000 USD
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2015Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2014Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34806797 shares
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
135338509 shares
CY2015Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash and cash equivalents. The Company has historically invested its cash equivalents in highly rated money market funds, corporate debt, federal agency notes and U.S. treasury notes. Investments, when purchased, are acquired in accordance with the Company&#8217;s investment policy which establishes a concentration limit per issuer. At </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;">, the Company&#8217;s cash equivalents are invested solely in money market funds.</font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company provides credit to customers in the normal course of business. The Company performs ongoing credit evaluations of its customers&#8217; financial condition and limits the amount of credit extended when deemed necessary. At </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;">, the Company&#8217;s accounts and unbilled receivables include </font><font style="font-family:inherit;font-size:10pt;">$656</font><font style="font-family:inherit;font-size:10pt;"> or </font><font style="font-family:inherit;font-size:10pt;">79%</font><font style="font-family:inherit;font-size:10pt;"> from U.S. and Canadian government grants and </font><font style="font-family:inherit;font-size:10pt;">$37</font><font style="font-family:inherit;font-size:10pt;"> or </font><font style="font-family:inherit;font-size:10pt;">5%</font><font style="font-family:inherit;font-size:10pt;"> from customer product sales. At </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;">, the Company&#8217;s Renewable Enhanced Feedstocks for Advanced Biofuels and Bioproducts ("REFABB") grant from the Department of Energy represented </font><font style="font-family:inherit;font-size:10pt;">55%</font><font style="font-family:inherit;font-size:10pt;"> of total receivables. At </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;">, the Company&#8217;s worldwide accounts and unbilled receivables include </font><font style="font-family:inherit;font-size:10pt;">$429</font><font style="font-family:inherit;font-size:10pt;"> or </font><font style="font-family:inherit;font-size:10pt;">74%</font><font style="font-family:inherit;font-size:10pt;"> from government grants and </font><font style="font-family:inherit;font-size:10pt;">$37</font><font style="font-family:inherit;font-size:10pt;"> or </font><font style="font-family:inherit;font-size:10pt;">6%</font><font style="font-family:inherit;font-size:10pt;"> from customer product sales. At </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;">, the Company&#8217;s REFABB grant from the Department of Energy represented </font><font style="font-family:inherit;font-size:10pt;">63%</font><font style="font-family:inherit;font-size:10pt;"> of total receivables.</font></div></div>
CY2015Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

Files In Submission

Name View Source Status
0001121702-15-000019-index-headers.html Edgar Link pending
0001121702-15-000019-index.html Edgar Link pending
0001121702-15-000019.txt Edgar Link pending
0001121702-15-000019-xbrl.zip Edgar Link pending
ex-311x20150331.htm Edgar Link pending
ex-312x20150331.htm Edgar Link pending
ex-321x20150331.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mblx-20150331.xml Edgar Link completed
mblx-20150331.xsd Edgar Link pending
mblx-20150331x10q.htm Edgar Link pending
mblx-20150331_cal.xml Edgar Link unprocessable
mblx-20150331_def.xml Edgar Link unprocessable
mblx-20150331_lab.xml Edgar Link unprocessable
mblx-20150331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending